CSI Market
Sign In | Register

Tff Pharmaceuticals Inc (TFFP) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access TFFP quarterly Cash Flow →
Looking at cash flow data from Tff Pharmaceuticals Inc through Dec 31 2019 provides insight into Dec 31 2023's financial flexibility across reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2023)
12 Months 		(Dec 31 2022) (Dec 31 2021) (Dec 31 2020) (Dec 31 2019)
Operating Activities
Income-21.24
Depreciation & amortization0.50
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue-0.03
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventory Write-down0.75
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation2.93
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants0.00
Increase Decrease Deferred Research Grant Revenue0.08
Receivable Due From Collaborations Agreement-0.18
Increase Decrease In Research And Development Tax Incentive Receivable4.25
Writeoff Of Constructioninprocess-
Increase Decrease In Contract With Customer Liability-
Interest Accrued On Note Receivable-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Employee Related Liabilities0.00
Increase (Decrease) in Accounts Payable0.04
Increase (Decrease) in Accrued Liabilities0.37
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-1.48
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-16.04
Investing Activities
Capital Expenditures-0.09
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.09
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-0.11
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock5.13
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Payments For Net Transfers From Parent-
Proceeds From Issuance Of Common Stock Value0.40
Proceeds From Issuance Of Common Stock For Stock Option Exercises0.11
Proceeds from Sales Of Common Stock And Warrants Through Offerings-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents-
Proceeds From Sales Of Common Stock And Warrants Through Offerings Net Of Offering Costs-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities5.01
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-16.13
Total Cash Flow-11.13
4 historic quarters locked

Sign in to unlock the full Tff Pharmaceuticals Inc cash flow history.

Sign In Create Free Account

About Tff Pharmaceuticals Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001213900-24-100587

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License